- D C Lefroy
- Department of Cardiology, Hammersmith Hospital, London W12 0HS.
Hypertrophic cardiomyopathy is a common cause of sudden death in apparently healthy young adults, and antiarrhythmic drugs may not prevent this outcome. Implantable defibrillator technology has progressed sufficiently for these devices to correct malignant cardiac arrhythmias and prevent sudden death in patients with hypertrophic cardiomyopathy. The identification of suitable patients is an important challenge since the non- arrhythmic prognosis of hypertrophic cardiomyopathy is relatively good.
Case history
A 35 year old woman collapsed at the wheel of her car after nearly hitting a lorry. Another car driver went to help and found her unconscious, cyanosed, and breathing noisily. Her pulse was initially very rapid and then disappeared. He started cardiopulmonary resuscitation by the roadside, and an ambulance arrived in about seven minutes. Defibrillation immediately ended the ventricular fibrillation and her pulse returned. After admission to hospital, her return to consciousness was slow but computed tomography of the brain showed no abnormality. Apart from some retrograde amnesia of the events leading up to her cardiac arrest, she recovered completely and was transferred to our hospital for further evaluation.
In 1990, she had had a single syncopal episode, and had been admitted to our hospital, where echocardiography had shown hypertrophic cardiomyopathy. At that time tilt testing caused abnormal hypotension associated with marked bradycardia after 34 minutes of tilting the head up 60°. In addition, the signal averaged surface electrocardiogram showed late potentials in the QRS complex, which suggested a predisposition to ventricular tachyarrhythmias. However, no episodes of ventricular tachycardia were observed on 24 hour electrocardiographic monitoring. She was started on amiodarone 200 mg daily and had no further syncopal episodes. She was therefore allowed to retain her driving licence. One year later her amiodarone dose was reduced to 200 mg three times weekly because of photosensitivity. Subsequently, she conceived and gave birth to healthy …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012